AraDMetjianMD

Assistant Professor of Medicine, Duke University School of Medicine

Dr. Metjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1665 Aurora Ct
Aurora, CO 80045
Phone+1 720-848-0000

Fax+1 720-848-1786

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2005 - 2007
University of North Carolina HospitalsResidency, Internal Medicine, 2001 - 2004
Drexel University College of MedicineClass of 2001

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era.
Ayotola A Fatola, Michael D Evans, Jenna Brown, Elizabeth Davis, Andrew David Johnson
Blood Advances. 2024-12-03
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.
Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun
Research and Practice in Thrombosis and Haemostasis. 2024-03-01
2 citations
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun
Blood Advances. 2024-02-13

Abstracts/Posters

Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen
Ara Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity
Ara Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
Ara Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
Ara Metjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Lectures

Update in Hematology
2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019